A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer
Clinical trial NCT01696877 · COMPLETED
Trial details
- NCT number
- NCT01696877
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-18
- Primary completion
- 2017-08-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.